Logo image of ECG

EVERUS CONSTRUCTION GROUP (ECG) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ECG - US3004261034 - Common Stock

91.96 USD
+1.25 (+1.38%)
Last: 11/28/2025, 8:25:18 PM
91.96 USD
0 (0%)
After Hours: 11/28/2025, 8:25:18 PM
Fundamental Rating

4

Overall ECG gets a fundamental rating of 4 out of 10. We evaluated ECG against 55 industry peers in the Construction & Engineering industry. ECG has only an average score on both its financial health and profitability. ECG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ECG had positive earnings in the past year.
ECG had a positive operating cash flow in the past year.
ECG Yearly Net Income VS EBIT VS OCF VS FCFECG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 11.14%, ECG is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 31.58%, ECG belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
With an excellent Return On Invested Capital value of 19.09%, ECG belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ECG is in line with the industry average of 17.30%.
Industry RankSector Rank
ROA 11.14%
ROE 31.58%
ROIC 19.09%
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ECG Yearly ROA, ROE, ROICECG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of ECG (5.18%) is better than 63.64% of its industry peers.
ECG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.92%, ECG perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of ECG has declined.
The Gross Margin of ECG (12.10%) is worse than 65.45% of its industry peers.
ECG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.92%
PM (TTM) 5.18%
GM 12.1%
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
ECG Yearly Profit, Operating, Gross MarginsECG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2 4 6 8 10

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ECG is creating value.
ECG has about the same amout of shares outstanding than it did 1 year ago.
ECG has a worse debt/assets ratio than last year.
ECG Yearly Shares OutstandingECG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
ECG Yearly Total Debt VS Total AssetsECG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 6.04 indicates that ECG is not in any danger for bankruptcy at the moment.
ECG's Altman-Z score of 6.04 is fine compared to the rest of the industry. ECG outperforms 80.00% of its industry peers.
The Debt to FCF ratio of ECG is 2.14, which is a good value as it means it would take ECG, 2.14 years of fcf income to pay off all of its debts.
ECG's Debt to FCF ratio of 2.14 is fine compared to the rest of the industry. ECG outperforms 76.36% of its industry peers.
ECG has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
ECG's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. ECG outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.14
Altman-Z 6.04
ROIC/WACC1.83
WACC10.42%
ECG Yearly LT Debt VS Equity VS FCFECG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

ECG has a Current Ratio of 1.76. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.76, ECG belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that ECG should not have too much problems paying its short term obligations.
The Quick ratio of ECG (1.69) is better than 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.69
ECG Yearly Current Assets VS Current LiabilitesECG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.30% over the past year.
Measured over the past years, ECG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.37% on average per year.
The Revenue has decreased by -0.16% in the past year.
Measured over the past years, ECG shows a quite strong growth in Revenue. The Revenue has been growing by 11.57% on average per year.
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.98%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%29.68%

3.2 Future

Based on estimates for the next years, ECG will show a small growth in Earnings Per Share. The EPS will grow by 7.77% on average per year.
ECG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.58% yearly.
EPS Next Y5.64%
EPS Next 2Y7.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.14%
Revenue Next 2Y14.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ECG Yearly Revenue VS EstimatesECG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 1B 2B 3B
ECG Yearly EPS VS EstimatesECG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.05, ECG can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ECG indicates a somewhat cheap valuation: ECG is cheaper than 72.73% of the companies listed in the same industry.
ECG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 28.07, ECG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as ECG.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, ECG is valued a bit cheaper.
Industry RankSector Rank
PE 26.05
Fwd PE 28.07
ECG Price Earnings VS Forward Price EarningsECG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ECG's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ECG is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 35.15
EV/EBITDA 17.64
ECG Per share dataECG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.62
PEG (5Y)N/A
EPS Next 2Y7.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ECG!.
Industry RankSector Rank
Dividend Yield N/A

EVERUS CONSTRUCTION GROUP

NYSE:ECG (11/28/2025, 8:25:18 PM)

After market: 91.96 0 (0%)

91.96

+1.25 (+1.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-10 2026-02-10
Inst Owners85.88%
Inst Owner Change4.15%
Ins Owners0.3%
Ins Owner Change0.78%
Market Cap4.69B
Revenue(TTM)3.49B
Net Income(TTM)180.96M
Analysts80
Price Target107.78 (17.2%)
Short Float %3.43%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)75.29%
Min EPS beat(2)72.75%
Max EPS beat(2)77.83%
EPS beat(4)3
Avg EPS beat(4)53.11%
Min EPS beat(4)-3.53%
Max EPS beat(4)77.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.59%
Min Revenue beat(2)17.63%
Max Revenue beat(2)23.55%
Revenue beat(4)4
Avg Revenue beat(4)18.41%
Min Revenue beat(4)11.43%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.3%
PT rev (3m)27.82%
EPS NQ rev (1m)26.51%
EPS NQ rev (3m)29.88%
EPS NY rev (1m)0%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)8.46%
Revenue NQ rev (3m)9.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.74%
Valuation
Industry RankSector Rank
PE 26.05
Fwd PE 28.07
P/S 1.34
P/FCF 35.15
P/OCF 24.78
P/B 8.19
P/tB 10.91
EV/EBITDA 17.64
EPS(TTM)3.53
EY3.84%
EPS(NY)3.28
Fwd EY3.56%
FCF(TTM)2.62
FCFY2.84%
OCF(TTM)3.71
OCFY4.04%
SpS68.51
BVpS11.23
TBVpS8.43
PEG (NY)4.62
PEG (5Y)N/A
Graham Number29.87
Profitability
Industry RankSector Rank
ROA 11.14%
ROE 31.58%
ROCE 25.96%
ROIC 19.09%
ROICexc 22.73%
ROICexgc 27.82%
OM 6.92%
PM (TTM) 5.18%
GM 12.1%
FCFM 3.82%
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)19.99%
ROICexc(5y)N/A
ROICexgc(3y)25.54%
ROICexgc(5y)N/A
ROCE(3y)26.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
F-Score7
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.14
Debt/EBITDA 1
Cap/Depr 199.03%
Cap/Sales 1.6%
Interest Coverage 11.49
Cash Conversion 70.13%
Profit Quality 73.74%
Current Ratio 1.76
Quick Ratio 1.69
Altman-Z 6.04
F-Score7
WACC10.42%
ROIC/WACC1.83
Cap/Depr(3y)170.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.98%
EPS Next Y5.64%
EPS Next 2Y7.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%29.68%
Revenue Next Year22.14%
Revenue Next 2Y14.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.33%
EBIT growth 3Y9.22%
EBIT growth 5YN/A
EBIT Next Year33.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.21%
FCF growth 3Y25.55%
FCF growth 5YN/A
OCF growth 1Y-4.65%
OCF growth 3Y24.12%
OCF growth 5YN/A

EVERUS CONSTRUCTION GROUP / ECG FAQ

Can you provide the ChartMill fundamental rating for EVERUS CONSTRUCTION GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to ECG.


What is the valuation status of EVERUS CONSTRUCTION GROUP (ECG) stock?

ChartMill assigns a valuation rating of 3 / 10 to EVERUS CONSTRUCTION GROUP (ECG). This can be considered as Overvalued.


How profitable is EVERUS CONSTRUCTION GROUP (ECG) stock?

EVERUS CONSTRUCTION GROUP (ECG) has a profitability rating of 4 / 10.


What is the valuation of EVERUS CONSTRUCTION GROUP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EVERUS CONSTRUCTION GROUP (ECG) is 26.05 and the Price/Book (PB) ratio is 8.19.


What is the financial health of EVERUS CONSTRUCTION GROUP (ECG) stock?

The financial health rating of EVERUS CONSTRUCTION GROUP (ECG) is 6 / 10.